Brief: Elicera Consolidates Management, Starts CEO Transition
24/07/2026 07:04
BRIEF-Elicera Consolidates Management, Starts CEO Transition July 24 (Reuters) - Elicera Therapeutics AB ELIC.ST:
CONSOLIDATES ITS MANAGEMENT IN UPPSALA: CEO TRANSITION BEGINS, RECRUITMENT OF NEW CEO HAS STARTED
JAMAL EL-MOSLEH TO REMAIN AS CEO UNTIL OCTOBER 31, 2026
Source text: ID:nWkr8jR3nr
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application